Figures & data
Table 1. Parameters used for fabricating chitosan, PLGA, gelatin and PCL fibrous scaffolds.
Figure 1. Schematics of double-ejection electrospinning (A), triple-layer artificial blood vessel scaffold (B) and cross-linking process (C).
![Figure 1. Schematics of double-ejection electrospinning (A), triple-layer artificial blood vessel scaffold (B) and cross-linking process (C).](/cms/asset/b7cba176-cb91-467d-a088-9fb99067fbff/tsta_a_11661062_f0001_oc.jpg)
Figure 2. SEM morphology of the outer layer of the artificial blood vessel: chitosan (a), PLGA (b), PLGA–chitosan (c) and cro-PLGA–chitosan scaffolds (d).
![Figure 2. SEM morphology of the outer layer of the artificial blood vessel: chitosan (a), PLGA (b), PLGA–chitosan (c) and cro-PLGA–chitosan scaffolds (d).](/cms/asset/b1d1f048-eb32-41af-9405-8ac32db88955/tsta_a_11661062_f0002_oc.jpg)
Figure 3. SEM morphology of the intermediate layer of the artificial blood vessel: gelatin (a), PLGA (b), PLGA–gelatin (c) and cro-PLGA–gelatin scaffolds (d).
![Figure 3. SEM morphology of the intermediate layer of the artificial blood vessel: gelatin (a), PLGA (b), PLGA–gelatin (c) and cro-PLGA–gelatin scaffolds (d).](/cms/asset/41c47860-25cb-49a7-af89-acecd5b88baf/tsta_a_11661062_f0003_oc.jpg)
Figure 4. SEM morphology of the inner layer of the artificial blood vessel: gelatin (a), PCL (b), PCL–gelatin (c) and cro-PCL–gelatin scaffolds (d).
![Figure 4. SEM morphology of the inner layer of the artificial blood vessel: gelatin (a), PCL (b), PCL–gelatin (c) and cro-PCL–gelatin scaffolds (d).](/cms/asset/6e64a105-71da-4e1d-b1ff-a40f75427426/tsta_a_11661062_f0004_oc.jpg)
Figure 5. Artificial blood vessels with different inner diameters (a), cross-section (b), the three layers of the PCL–gelatin/PLGA–gelatin/PLGA–chitosan fibrous tube stained in different colors (c), (d) and the bilayers of the PCL–gelatin/PLGA–chitosan fibrous tube (e).
![Figure 5. Artificial blood vessels with different inner diameters (a), cross-section (b), the three layers of the PCL–gelatin/PLGA–gelatin/PLGA–chitosan fibrous tube stained in different colors (c), (d) and the bilayers of the PCL–gelatin/PLGA–chitosan fibrous tube (e).](/cms/asset/6cc077ec-15f5-46f7-951c-371fea400645/tsta_a_11661062_f0005_oc.jpg)
Figure 6. Stress–strain curves and corresponding SEM morphology of PCL–gelatin/PLGA–gelatin/PLGA–chitosan ABV scaffold: non-cross-linked (a1-2) and cross-linked (b1-2).
![Figure 6. Stress–strain curves and corresponding SEM morphology of PCL–gelatin/PLGA–gelatin/PLGA–chitosan ABV scaffold: non-cross-linked (a1-2) and cross-linked (b1-2).](/cms/asset/758130dc-3122-49b4-a5cf-1dd619427926/tsta_a_11661062_f0006_oc.jpg)
Figure 7. Burst strength of non-cross-linked and cross-linked PCL–gelatin/PLGA–gelatin/PLGA–chitosan scaffolds.
![Figure 7. Burst strength of non-cross-linked and cross-linked PCL–gelatin/PLGA–gelatin/PLGA–chitosan scaffolds.](/cms/asset/1f143a20-6461-4706-9e70-07f18a456b16/tsta_a_11661062_f0007_oc.jpg)
Figure 8. Cytotoxicity of electrospun PCL–gelatin, cro-PCL–gelatin, gelatin–PLGA , cro-gelatin–PLGA, PLGA–chitosan and cro-PLGA–chitosan scaffolds.
![Figure 8. Cytotoxicity of electrospun PCL–gelatin, cro-PCL–gelatin, gelatin–PLGA , cro-gelatin–PLGA, PLGA–chitosan and cro-PLGA–chitosan scaffolds.](/cms/asset/1191d354-e218-475a-8ba7-58608ae3473d/tsta_a_11661062_f0008_oc.jpg)
Figure 9. Optical absorbance of fibroblast cells seeded on PLGA–chitosan, cro-PLGA–chitosan and TCPS or endothelial cells seeded on PCL–gelatin, cro-PCL–gelatin and TCPS after 1, 3 and 5 days of incubation.
![Figure 9. Optical absorbance of fibroblast cells seeded on PLGA–chitosan, cro-PLGA–chitosan and TCPS or endothelial cells seeded on PCL–gelatin, cro-PCL–gelatin and TCPS after 1, 3 and 5 days of incubation.](/cms/asset/e0598df4-9956-415d-8cc8-439713c409f8/tsta_a_11661062_f0009_oc.jpg)